Gyre Therapeutics (GYRE) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.76% |
| Dec 31, 2025 | -42.45% |
| Sep 30, 2025 | -2.06% |
| Jun 30, 2025 | 50.58% |
| Mar 31, 2025 | 35.87% |
| Dec 31, 2024 | 29.64% |
| Sep 30, 2024 | 29.24% |
| Jun 30, 2024 | 27.88% |
| Mar 31, 2024 | 28.48% |
| Dec 31, 2023 | 69.45% |
| Sep 30, 2023 | 72.24% |
| Jun 30, 2023 | 53.86% |
| Mar 31, 2023 | 50.54% |
| Dec 31, 2022 | 26.67% |
| Sep 30, 2022 | 46.03% |
| Jun 30, 2022 | 7.07% |
| Mar 31, 2022 | -11.56% |
| Dec 31, 2021 | 26.73% |
| Sep 30, 2021 | -21.42% |
| Jun 30, 2021 | -22.81% |
| Mar 31, 2021 | -1.10% |
| Dec 31, 2020 | -44.96% |
| Sep 30, 2020 | -83.32% |
| Jun 30, 2020 | -45.14% |
| Mar 31, 2020 | -56.27% |
| Dec 31, 2019 | -66.95% |
| Sep 30, 2019 | -95.96% |
| Jun 30, 2019 | -57.70% |
| Mar 31, 2019 | 3.23% |
| Dec 31, 2018 | -54.18% |
| Sep 30, 2018 | 0.65% |
| Jun 30, 2018 | -25.06% |
| Mar 31, 2018 | -55.48% |
| Dec 31, 2017 | -186.78% |
| Sep 30, 2017 | 33.11% |
| Jun 30, 2017 | 26.76% |
| Mar 31, 2017 | 34.45% |
| Dec 31, 2016 | 9.92% |
| Sep 30, 2016 | 41.35% |
| Jun 30, 2016 | 37.94% |
| Mar 31, 2016 | 36.85% |
| Dec 31, 2015 | 11.02% |
| Sep 30, 2015 | 36.52% |
| Jun 30, 2015 | 46.56% |
| Mar 31, 2015 | 42.41% |
| Dec 31, 2014 | 78.94% |
| Sep 30, 2014 | 36.06% |
| Jun 30, 2014 | 25.17% |
| Mar 31, 2014 | 11.19% |
| Dec 31, 2013 | 42.51% |
| Sep 30, 2013 | 19.55% |
| Jun 30, 2013 | 23.25% |